These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 7526215

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 63. Hepatitis C virus and intravenous immune globulin.
    Macy E.
    JAMA; 1997 Feb 26; 277(8):627; author reply 627-8. PubMed ID: 9039874
    [No Abstract] [Full Text] [Related]

  • 64. [Role of host in spontaneous recovery from viral hepatitis C: the body's condition at the moment of infection].
    Isaguliants MG, Ozeretskovskaia NN, Znoĭko OO, Tsyganova EV.
    Vopr Virusol; 2008 Feb 26; 53(2):4-9. PubMed ID: 18450102
    [Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66. Prevalence of hepatitis C virus genotypes in Italy.
    Pistello M, Maggi F, Vatteroni L, Cecconi N, Panicucci F, Bresci GP, Gambardella L, Taddei M, Bionda A, Tuoni M.
    J Clin Microbiol; 1994 Jan 26; 32(1):232-4. PubMed ID: 8126188
    [Abstract] [Full Text] [Related]

  • 67. Possible transmission of hepatitis C virus infection with intravenous immunoglobulin.
    Schiano TD, Bellary SV, Black M.
    Ann Intern Med; 1995 May 15; 122(10):802-3. PubMed ID: 7717610
    [No Abstract] [Full Text] [Related]

  • 68.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 69. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.
    Lever AM, Webster AD, Brown D, Thomas HC.
    Lancet; 1984 Nov 10; 2(8411):1062-4. PubMed ID: 6150140
    [Abstract] [Full Text] [Related]

  • 70. Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon.
    Lockner D, Bratt G, Lindborg A, Törnebohm E.
    Acta Med Scand; 1987 Nov 10; 221(4):413-5. PubMed ID: 3111178
    [Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72. Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy.
    Thomson BJ, Doran M, Lever AM, Webster AD.
    Lancet; 1987 Mar 07; 1(8532):539-41. PubMed ID: 2434816
    [Abstract] [Full Text] [Related]

  • 73. Testing for HCV-RNA in commercial intravenous immunoglobulins.
    Lefrère JJ, Mariotti M, Trepo C, Li JS, Lunel F, Frangeul L, Letourneur F, Laporte JP, Jullien AM.
    Lancet; 1993 Mar 27; 341(8848):834-5. PubMed ID: 8096039
    [No Abstract] [Full Text] [Related]

  • 74.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Clinical experience with the viral safety of immunoglobulins.
    Hellstern P.
    Blood Coagul Fibrinolysis; 1994 Dec 27; 5 Suppl 3():S31-4; discussion S35. PubMed ID: 7749046
    [Abstract] [Full Text] [Related]

  • 77.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 78. Infectious hazards of immune globulin.
    Barton LL.
    J Pediatr; 1995 Feb 27; 126(2):321-2. PubMed ID: 7844688
    [No Abstract] [Full Text] [Related]

  • 79.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 80.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.